Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ustekinumab in Moderate to Severe Crohn's Disease (CERTIFI)
NCT00771667Phase 2Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Dec 2008
- Primary completion
- May 2010
- Modality
- Monoclonal Antibodies
- Countries
- 12
01
Overview
A Phase 2 trial of ustekinumab in Crohn's disease, sponsored by Janssen Pharmaceutical. Started Dec 2008; status: completed.
02
Drugs
ustekinumab
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT00771667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00771667.